These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 34112704)

  • 1. Another new application of heparin in COVID-19: more than anticoagulation and antiviral.
    Yu X
    J Investig Med; 2021 Aug; 69(6):1258. PubMed ID: 34112704
    [No Abstract]   [Full Text] [Related]  

  • 2. Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients: comment.
    Allione A; Giamello JD; Paglietta G; Bernardi S; Cavalot G
    Intern Emerg Med; 2021 Mar; 16(2):519-520. PubMed ID: 32440985
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial.
    Houston BL; Lawler PR; Goligher EC; Farkouh ME; Bradbury C; Carrier M; Dzavik V; Fergusson DA; Fowler RA; Galanaud JP; Gross PL; McDonald EG; Husain M; Kahn SR; Kumar A; Marshall J; Murthy S; Slutsky AS; Turgeon AF; Berry SM; Rosenson RS; Escobedo J; Nicolau JC; Bond L; Kirwan BA; de Brouwer S; Zarychanski R
    Clin Trials; 2020 Oct; 17(5):491-500. PubMed ID: 32815416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of anticoagulation use with SARS-CoV2 detection.
    Kavecansky J; Dusendang JR; Tavakoli J; Schmittdiel J; Ho G; Loyles J; Pai A
    Thromb Res; 2021 Feb; 198():99-102. PubMed ID: 33310348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinically significant anticardiolipin antibodies associated with COVID-19.
    Hossri S; Shadi M; Hamarsha Z; Schneider R; El-Sayegh D
    J Crit Care; 2020 Oct; 59():32-34. PubMed ID: 32512349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lessons from the Italian COVID-19 frontline.
    Bellan M; Sainaghi PP; Gavelli F; Patrucco F; Avanzi GC; Pirisi M; Castello LM
    Minerva Med; 2020 Aug; 111(4):303-305. PubMed ID: 33032392
    [No Abstract]   [Full Text] [Related]  

  • 8. In non-critically ill patients with COVID-19, therapeutic anticoagulation improved survival to discharge without organ support.
    Donato AA
    Ann Intern Med; 2021 Dec; 174(12):JC134. PubMed ID: 34871053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermediate versus standard dose heparin prophylaxis in COVID-19 ICU patients: A propensity score-matched analysis.
    Moll M; Zon RL; Sylvester KW; Rimsans J; Chen EC; Ghosh AJ; Abston E; Kim A; Rutherford H; Mitre X; Hakim A; Connell NT; Battinelli E; Fredenburgh LE; Baron RM; Hobbs BD; Cho MH; Mittleman MA; Woolley AE; Connors JM
    Thromb Res; 2021 Jul; 203():57-60. PubMed ID: 33940309
    [No Abstract]   [Full Text] [Related]  

  • 10. Heparin failure and COVID-19: Should we explore other anticoagulants? An observational report regarding in-vitro recovery of anticoagulant action in COVID-19 patients in intensive care.
    Thomas W; White D; Cox-Morton S; MacDonald S; Besser M
    Thromb Res; 2020 Nov; 195():226-227. PubMed ID: 32795720
    [No Abstract]   [Full Text] [Related]  

  • 11. The Benefits of Heparin Use in COVID-19: Pleiotropic Antiviral Activity beyond Anticoagulant and Anti-Inflammatory Properties.
    Lippi G; Henry BM; Favaloro EJ
    Semin Thromb Hemost; 2023 Feb; 49(1):73-75. PubMed ID: 35158389
    [No Abstract]   [Full Text] [Related]  

  • 12. COVID-19 Experience in Hemodialysis Patients: A Cue for Therapeutic Heparin-Based Strategies?
    Pisani A; Rizzo M; Angelucci V; Riccio E
    Nephron; 2020; 144(8):383-385. PubMed ID: 32526763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulopathy monitoring and anticoagulation management in COVID-19 patients on ECMO: Advantages of a heparin anti-Xa-based titration strategy.
    Rhoades R; Leong R; Kopenitz J; Thoma B; McDermott L; Dovidio J; Barletti S; Gong JZ; Massey HT; McKenzie SE; Rame JE; Al-Rawas N
    Thromb Res; 2021 Jul; 203():1-4. PubMed ID: 33894473
    [No Abstract]   [Full Text] [Related]  

  • 14. Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients: comment.
    Roncon L; Zuin M; Rigatelli G
    Intern Emerg Med; 2021 Mar; 16(2):517-518. PubMed ID: 32378044
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapeutic Anticoagulation with Heparin in Patients with Covid-19. Reply.
    Zarychanski R; Lawler PR; Goligher E
    N Engl J Med; 2021 Nov; 385(21):2014. PubMed ID: 34788517
    [No Abstract]   [Full Text] [Related]  

  • 16. COVID-19 coagulopathy: an evolving story.
    The Lancet Haematology
    Lancet Haematol; 2020 Jun; 7(6):e425. PubMed ID: 32470428
    [No Abstract]   [Full Text] [Related]  

  • 17. Interpreting recent clinical studies for COVID-19: A continual process with more new data.
    Connors JM; Moll M; Levy JH
    Anaesth Crit Care Pain Med; 2022 Feb; 41(1):101016. PubMed ID: 34958999
    [No Abstract]   [Full Text] [Related]  

  • 18. A Ghana-UK haematology "heparin" partnership.
    Olayemi E; Davies R; Bates I
    Br J Haematol; 2020 Nov; 191(3):e96-e97. PubMed ID: 32798238
    [No Abstract]   [Full Text] [Related]  

  • 19. COVID-19 infection in symptomatic pregnant women at the midpoint of the pandemic in Spain: a retrospective analysis.
    Ortiz Molina E; Hernandez Pailos R; Pola Guillen M; Pascual Pedreno A; Rodriguez Rodriguez E; Hernandez Martinez A
    Ginekol Pol; 2020; 91(12):755-763. PubMed ID: 33447995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Agents Against COVID-19 with Clinical Evidence.
    Tian C; Xiang M
    Curr Pharm Des; 2021; 27(13):1608-1617. PubMed ID: 33459226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.